Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INZ-701 in Adults With ABCC6 Deficiency Manifesting as PXE
NCT05030831Phase 2Completed
- Sponsor
- Inozyme Pharma
- Start
- Apr 2022
- Primary completion
- Jul 2024
- Modality
- Replacement Enzymes, Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of INZ-701 in pseudoxanthoma elasticum (PXE), sponsored by Inozyme Pharma. Started Apr 2022; status: completed.
02
Drugs
INZ-701
03
Conditions
pseudoxanthoma elasticum (PXE)
Beyond the preview
Go deeper on NCT05030831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05030831.